Personalised dendritic cell vaccine increases survival in patients with deadly brain cancer

A dendritic cell vaccine personalised for each individual based on the patient's own tumour may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Centre has found...

Read the whole article on

More from